Compounds > 5'-palmitoyl cytarabine
Page last updated: 2024-08-23

5'-palmitoyl cytarabine and Myelodysplastic Syndromes

5'-palmitoyl cytarabine has been researched along with Myelodysplastic Syndromes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kimura, K; Ohno, R1

Other Studies

1 other study(ies) available for 5'-palmitoyl cytarabine and Myelodysplastic Syndromes

ArticleYear
[Treatment of myelodysplastic syndromes (MDS) with oral administration of N4-palmitoyl-1-beta-D-arabinofuranosyl cytosine (PLAC)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:4 Pt 2-2

    Topics: Administration, Oral; Adult; Aged; Anorexia; Antineoplastic Agents; Cytarabine; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Nausea

1988